A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Clinical trial NCT01839604 · COMPLETED

Trial details

NCT number: NCT01839604
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Adult Hepatocellular Carcinoma Hepatocellular Carcinoma Metastatic

Start date: 2013-05-01
Primary completion: 2015-02-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.